<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144639">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01940185</url>
  </required_header>
  <id_info>
    <org_study_id>3545</org_study_id>
    <nct_id>NCT01940185</nct_id>
  </id_info>
  <brief_title>A Post-Approval Study of the LINX® Reflux Management System</brief_title>
  <official_title>A Post-Approval Study of the LINX® Reflux Management System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Torax Medical Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Torax Medical Incorporated</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter,
      single-arm study, with patients as their own control to monitor the safety and efficacy of
      the LINX implant procedure and device in a post-approval environment to supplement existing
      safety and efficacy data.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Successful reduction of total GERD-HRQL score</measure>
    <time_frame>6 months, 12 months, and annually to 60 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Serious, device-related adverse events</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of device-related adverse events, reduction in use of daily acid suppression therapy, frequency and severity of heartburn and regurgitation, extra-esophageal symptoms and side effect profile</measure>
    <time_frame>6 months, 12 months, and annually to 60 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastroesophageal Reflux Disease (GERD)</condition>
  <arm_group>
    <arm_group_label>LINX device</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LINX device</intervention_name>
    <arm_group_label>LINX device</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with Gastroesophageal Reflux Disease (GERD) as defined by abnormal pH
        testing, and who continue to have chronic GERD symptoms despite maximum medical therapy
        for the treatment of reflux
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is a candidate for treatment with the LINX Reflux Management System

          -  Patient has provided written informed consent for participation in the post-approval
             study.

          -  Patient has indicated a willingness to comply with study requirements and the
             follow-up schedule and assessments.

          -  Patient has been diagnosed with GERD as defined by abnormal pH testing.

          -  Patient continues to have chronic GERD symptoms despite maximum medical therapy for
             the treatment of reflux.

        Exclusion Criteria:

          -  Patients with suspected or known allergies to titanium, stainless steel, nickel, or
             ferrous materials.

          -  Known circumstances that would make it unlikely for the patient to complete follow-up
             through 60 months.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amy Derosier</last_name>
    <phone>651-361-8900</phone>
    <email>aderosier@toraxmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Keck Medical Center of Univeristy of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Biersack</last_name>
      <email>Michelle.Biersack@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>John Lipham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Lazar</last_name>
      <email>seschultz@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Garth Jacobsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center/SurgOne</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Hitz</last_name>
      <email>carolyn@sofisite.com</email>
    </contact>
    <investigator>
      <last_name>Reginald Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoebe Putney Memorial Hospital</name>
      <address>
        <city>Albany</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Brice</last_name>
      <email>sebrice@mindspring.com</email>
    </contact>
    <investigator>
      <last_name>Chris Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Candler Hospital</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dwan Fellows</last_name>
      <email>dwan@fellowsresearch.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Mandel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aishatu Aloma</last_name>
      <email>aaloma@caregroup.org</email>
    </contact>
    <investigator>
      <last_name>Michael Kent, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marsha Williams</last_name>
      <email>mhwilliams@nmhs.net</email>
    </contact>
    <investigator>
      <last_name>John Averette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center - Geauga</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Ermlich</last_name>
      <email>bridget.ermlich@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Leena Khaitan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Dettorre</last_name>
      <email>Becky.Dettorre@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Kyle Perry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Knox Community Hospital</name>
      <address>
        <city>Mount Vernon</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Haire</last_name>
      <email>Kathy.Haire@KnoxCommHosp.org</email>
    </contact>
    <investigator>
      <last_name>Paul Taiganides, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Oregon Clinic</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angi Gill</last_name>
      <email>agill@orclinic.com</email>
    </contact>
    <investigator>
      <last_name>Christy Dunst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny Western Pennsylvania Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Lloyd</last_name>
      <email>elloyd@wpahs.org</email>
    </contact>
    <investigator>
      <last_name>Blair Jobe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Hospital Center</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Divya Bansal, PA-C</last_name>
      <email>dxb3580@virginiahospitalcenter.com</email>
    </contact>
    <investigator>
      <last_name>G. Kevin Gillian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Brennan</last_name>
      <email>Christina.Brennan@swedish.org</email>
    </contact>
    <investigator>
      <last_name>Brian Louie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gundersen Lutheran Medical Center</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Quinnell</last_name>
      <email>aequinne@gundersenhealth.org</email>
    </contact>
    <investigator>
      <last_name>Shanu Kothari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Froedtert and Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Frelich</last_name>
      <email>mfrelich@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Jon Gould, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 7, 2014</lastchanged_date>
  <firstreceived_date>September 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
